Gilead Sciences (GILD)
Nasdaq
GILD: Gilead Sciences last traded at $151.28 (-0.61%) on NASDAQ. Stock price, quote and news on TechGraph.
Current Gilead Sciences forecasts and price targets
Analyst figures are shown only when the research feed provides them.
Scroll here to load data.
People also watch
Trending global stocks
Related in Drug Manufacturers—General
About Gilead Sciences
Gilead Sciences, Inc. () is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy.…
From the companyLearn about the biopharmaceutical company Gilead Sciences, including mission, vision, values, history, impact, leadership, therapeutic areas and other information.
Technical analysis
| Indicator | Call | Detail |
|---|---|---|
| Price vs SMA 20 | Sell | Last close is below the 20-session average. |
| Price vs SMA 50 | Buy | Medium-term trend is still up. |
| SMA cross | Buy | The 20-session average is above the 50-session average. |
| RSI (14) | Neutral | RSI is in the mid-range. |
| MACD | Buy | MACD line is above zero. |
| Stochastic | Buy | Stochastic %K is oversold. |
Company profile
Gilead Sciences executives and management
Gilead Sciences financials and ownership
Gilead Sciences revenue, operating income and earnings per share
Annual figures are charted only when the provider supplies comparable periods.
Scroll here to load data.
Key financial metrics
Financial Highlights
| Profit Margin | N/A |
| Operating Margin | N/A |
| Return on Assets | N/A |
| Return on Equity | N/A |
| Revenue | N/A |
| Quarterly Revenue Growth | N/A |
| Diluted EPS | N/A |
Balance Sheet
| Total Cash | N/A |
| Total Debt | N/A |
| Total Debt/Equity | N/A |
| Current Ratio | N/A |
| Book Value Per Share | N/A |
Cash Flow Statement
| Operating Cash Flow | N/A |
| Levered Free Cash Flow | N/A |
Share Statistics
| Avg Vol (3 month) | 5.00M |
| Shares Outstanding | 1.25B |
| Float | N/A |
| Short Ratio | N/A |
| Short % of Float | N/A |
Major Holders
| % of Shares Held by All Insiders | N/A |
| % of Shares Held by Institutions | N/A |
| % of Float Held by Institutions | N/A |
| Number of Institutions Holding Shares | N/A |
Financial statement fields will appear when the market-data feed provides usable fundamentals for this instrument.
Gilead Sciences revenue by segment
Scroll here to load data.
Gilead Sciences revenue by region
Scroll here to load data.
Gilead Sciences stock margins
Scroll here to load data.
Gilead Sciences historical valuation
Scroll here to load data.
Gilead Sciences annual returns
Scroll here to load data.
Gilead Sciences financial statements
Income statement, balance sheet and cash flow, with annual and quarterly periods.
Scroll here to load statements.
News & official updates
Gilead Sciences fair value
Scroll here to load data.
Gilead Sciences options chain
Scroll here to load data.
Gilead Sciences — frequently asked questions
What is the price of Gilead Sciences (GILD) today?
Gilead Sciences (GILD) last traded at $151.28 (-0.61%) on NASDAQ, according to TechGraph market data.
Where is Gilead Sciences listed?
Gilead Sciences trades as GILD on Nasdaq.
What is the 52-week range for GILD?
The 52-week range for GILD is $108.46 to $157.29.
What does Gilead Sciences do?
Gilead Sciences is a listed drug manufacturers—general company in the healthcare sector, traded on NASDAQ.
Price quotes refresh periodically while this page stays open; the chart follows the quote and refreshes exchange history less often. Some venues delay data by 0–15 minutes. When the market is closed, the last recorded session price is shown. Fundamentals refresh on a slower schedule.